Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Omnibus Health topic
No spam. Unsubscribe anytime.
Omnibus health bill HB 4040 brings targeted fixes on prosthetics, prescription oversight and dental notifications amid debate
Summary
Committee reviewed HB 4040 omnibus amendments including a prosthetics language fix to remove 'not solely for comfort or convenience,' proposed adjustments to the Prescription Drug Affordability Board's insulin review, and a contentious dental patient-notice amendment that split providers and subcontractors.
The House Committee on Health Care held an extensive public hearing on the committee omnibus, HB 4040, with numerous amendments and narrowly tailored policy changes.
A small but widely supported technical fix (dash-7) would remove the phrase "not solely for comfort or convenience" from the statute governing prosthetic and orthotic coverage; Nicole Verkailen of the Amputee Coalition and other advocates called it a dignity and access change. "These devices are not luxuries," Verkailen said, urging adoption of the amendment.
A biotechnology industry representative asked that dash-14 align PDAB's insulin review flexibility with changes enacted last year for other drug reviews; proponents said the amendment would mirror SB 289's approach for insulin products.
One of the most contested proposals was dash-21, a change to dental subcontractor communications that would require dentists to be able to notify active patients of a change in subcontractor arrangements and advise them of options to continue care. Proponents (practicing dentists and patient advocates) said patients of record sometimes receive notices that do not explain their right to follow a provider; opponents (representatives of dental subcontractors, CCOs and insurers) argued the draft language risked running afoul of federal marketing rules and would create perverse incentives and churn in Medicaid dental networks.
"A patient has the right today, but a right that they don't know about isn't a right," testified Jim Bunn, arguing for a clear notification requirement and OHA-prescribed language. Insurer and DCO representatives warned the provision could duplicate existing federal and state rules and inadvertently create marketing issues.
Other omnibus provisions discussed included changes to primary-care automatic assignment (dash-11), protections for family caregivers as personal support workers (dash-13), and timing changes for anesthesia limits (dash-3); stakeholders and regulators said some language required further work to avoid unintended consequences. The Prescription Drug Affordability Board chair asked that governor appointment language (a dash change) not be adopted, warning it could undermine perceived independence.
The committee closed the hearing after a full day of testimony and said staff would circulate further amendments and that the chair and stakeholders would continue negotiations on disputed language.
Next steps: committee staff and sponsors will refine amendment text and resolve federal marketing and administrative conflicts before floor consideration.
